Clinical Trial Update: Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on pulsed reduced dose radiotherapy used upfront for glioblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING